1998 – 2000
Duke University Medical Center
Douglas Tyler, M.D.
Immunotherapy of Pancreatic Cancer Using Dendritic Cells Pulsed with Antigen in the Form of Amplified Total Tumor R
Johns Hopkins Medical Institutions
Michael Goggins, M.D.
Detect Early Symptomless Pancreatic Cancer
Johns Hopkins Medical Institutions
Constance Griffin, M.D.
Chromosome Analysis in Patients with Familial Pancreatic Cancer
Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
A Phase II Study of an Allogeneic Gm-CSF Secreting Pancreatic Tumor Vaccine
University of Texas M.D. Anderson Cancer Center
Keping Xie, M.D., Ph.D.
Control of Pancreatic Cancer Metastasis by Modulating Tumor-associated Nitric Oxide Production
Creighton University School of Medicine
Thomas Adrian, Ph.D.
LOX Inhibitors for Pancreatic Cancer Treatment and Prevention
University of California at San Francisco Comprehensive Cancer Center
Margaret Tempero, M.D.
Optimizing Therapy for Pancreatic Adenocarcinoma with TALL-104 Cells
University of Texas at San Antonio
James Freeman, Ph.D.
TGF-B Type II Receptor Gene as a Target for the Antitumor Effect of Farnesyltransferace Inhibitors in Pancreatic Cancer
University of Texas M.D. Anderson Cancer Center
Robert Radinsky, Ph.D.
Blocking Tumor Growth Factor Receptors in Pancreatic Tumor Cells
* Collaborating Institution(s)